Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II study (Q40739600)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 1992

edit

Language	Label	Description	Also known as
English	Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II study	scientific article published on January 1, 1992

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

retrieved

23 September 2017

title

Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II study (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

main subject

leukemia

1 reference

based on heuristic

inferred from title

author name string

S. H. Lim

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

A. C. Newland

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

S. Kelsey

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

A. Bell

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

E. Offerman

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

C. Rist

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

D. Gozzard

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

D. Bareford

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

M. P. Smith

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

A. H. Goldstone

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1540980

retrieved

6 October 2022

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

1540980

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1540980

retrieved

6 October 2022

publication date

1 January 1992

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

retrieved

23 September 2017

published in

Cancer Immunology, Immunotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

retrieved

23 September 2017

volume

34

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

retrieved

23 September 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

retrieved

23 September 2017

page(s)

337-342

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

retrieved

23 September 2017

cites work

Thyroid disorders in 2 cases of acute myeloid leukaemia following treatment with recombinant interleukin-2 infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human natural killer cells can inhibit clonogenic growth of fresh leukemic cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of tumour-derived suppressor factor in patients with acute myeloid leukaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 augments natural killer cell activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term culture of tumour-specific cytotoxic T cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular cytotoxic function and potential in acute myelogenous leukaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in the understanding of the biochemistry and clinical pharmacology of interleukin-2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1540980

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF01741555

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

retrieved

23 September 2017

Dimensions Publication ID

1023171844

0 references

PubMed publication ID

1540980

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1540980

retrieved

23 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40739600&oldid=2203939216"